Acción RMDA TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Acciones

RMDA

EGS381B1C015

Precio de cierre Egyptian Exchange
Otros sitios de cotización
 00:00:00 27/06/2024 		Varia. Cinco días. Varia. 1 de enero.
2,38 EGP +2,59 % Gráfico intradía de Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. +9,17 % +44,24 %
14/05 Décima de Ramadán para Industrias Farmacéuticas y Reactivos de Diagnóstico (Rameda) S.A.E. informa de los resultados de ganancias para el primer trimestre finalizado el 31 de marzo de 2024 CI
19/03 Décima de Ramadán para Industrias Farmacéuticas y Reactivos de Diagnóstico (Rameda) S.A.E. informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E.(CASE:RMDA) dropped from EGX 30 Index
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Ekuity B.V. acquired additional 5.38% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for approximately EGP 160 million.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. announces an Equity Buyback for 10% of its issued share capital.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. authorizes a buyback plan.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
The Saudi Seventh Investment Company agreed to acquire additional 6.5% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for GGP 135 million.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda E : Pharmaceutical Industries & Diagnostic - Rameda (RMDA.CA) - Listing Committee Decision
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda E : Pharmaceutical Industries & Diagnostic - Rameda (RMDA.CA) Reports Year Ended 31/12/2021 Consolidated Results
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E.(CASE:RMDA) added to EGX 30 Index
Equinox Pharma Holding Ltd. acquired additional 2.71% minority stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for EGP 58.3 million.
STenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Announce Audited Consolidated Earnings Results for the Quarter Ended March 31, 2021
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción RMDA
  4. Noticias Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
  5. Otros idiomas